PMVP - PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June | Benzinga
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences in June. Management will also participate in one-on-one investor meetings.
Jefferies Global Healthcare Conference (June 5 – 6, 2024)
Format: Fireside Chat
Date: Thursday, June 6, ...